5-(2-bromoprop-2-en-1-yl)-5-(prop-2-en-1-yl)-1,3-diazinane-2,4,6-trione

• ChemBase编号: 130295
• 分子式: C10H11BrN2O3
• 平均质量: 287.10994
• 单一同位素质量: 285.99530422
• SMILES: O=C1NC(=O)NC(=O)C1(CC(=C)Br)CC=C
• Canonical SMILES: C=CCC1(CC(=C)Br)C(=O)NC(=O)NC1=O
• InChI: InChI=1S/C10H11BrN2O3/c1-3-4-10(5-6(2)11)7(14)12-9(16)13-8(10)15/h3H,1-2,4-5H2,(H2,12,13,14,15,16)
• InChIKey: DYODAJAEQDVYFX-UHFFFAOYSA-N

名称和登记号

名称

• IUPAC标准名: 5-(2-bromoprop-2-en-1-yl)-5-(prop-2-en-1-yl)-1,3-diazinane-2,4,6-trione
• IUPAC传统名: brallobarbital
• 别名: 5-(2-Bromo-2-propen-1-yl)-5-(2-propen-1-yl)-2,4,6(1H,3H,5H)-pyrimidinetrione; 5-(2'-Bromallyl)-5-allylbarbituric Acid; 5-Allyl-5-(2-bromoallyl)barbituric Acid; Allylbromoallylbarbituric Acid; Brallobarbitone; U. C. B. 5033; Ucedorm; Vesperone; Brallobarbital; Brallobarbital

登记号

• CAS号: 561-86-4
• PubChem SID: 162224574
• PubChem CID: 68416
• Chemspider ID: 61699
• 美国药典/FDA物质标识码: D0N7A2M3MU
• 维基百科标题: Brallobarbital

理论计算性质

• Acid pKa: 8.2279415
• 质子受体: 3
• 质子供体: 2
• LogD (pH = 5.5): 1.2430172
• LogD (pH = 7.4): 1.1843795
• Log P: 1.2438197
• 摩尔折射率: 61.2307 cm^3
• 极化性: 23.374355 Å^3
• 极化表面积: 75.27 Å^2
• 可自由旋转的化学键: 4
• 里宾斯基五规则: true

详细说明

Toronto Research Chemicals - B676750

Brallobarbital is a barbiturate derivative and the brominated analogue of Allobarbital (A544500). Brallobarbital has sedative and hypnotic properties and was used for the treatment of insomnia.Brallobarbital is a Controlled Substance.

参考文献

• Maurer, H.H.: J. Chrom Biomed. Appl., 530, 307 (1990)
• Wollheim, F.: Acta Pharmacol. Toxicol., 15, 1 (1990)
• Hermans, R.B. et al.: Pharmac. Week., 102, 1123 (1967):